Clinical trials of mitotic kinesin inhibitors

Steven S. Rosenfeld

doi:10.1007/978-94-017-9732-0_4

Clinical trials of mitotic kinesin inhibitors

Steven S. Rosenfeld

Hematology / Oncology / Cancer Center / Breast Clinic

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

Abnormal mitotic activity underlies the pathology of a number of human diseases, most notably cancer, and has motivated the search for more specific and less toxic inhibitors of the mitotic process. In this chapter, I review the clinical experience with one group of inhibitors that target mitotic kinesins. I will discuss the results of phase I and II trials with these drugs and place the results of these trials in a context to explain how they can be utilized in future human studies.

Original language	English (US)
Title of host publication	Kinesins and Cancer
Publisher	Sense Publishers
Pages	63-76
Number of pages	14
ISBN (Electronic)	9789401797320
ISBN (Print)	9789401797313
DOIs	https://doi.org/10.1007/978-94-017-9732-0_4
State	Published - Jan 1 2015

ASJC Scopus subject areas

Medicine(all)
Biochemistry, Genetics and Molecular Biology(all)
Chemistry(all)

Access to Document

10.1007/978-94-017-9732-0_4

Cite this

@inbook{13015be9decf4ce8baa545575b97dba9,

title = "Clinical trials of mitotic kinesin inhibitors",

abstract = "Abnormal mitotic activity underlies the pathology of a number of human diseases, most notably cancer, and has motivated the search for more specific and less toxic inhibitors of the mitotic process. In this chapter, I review the clinical experience with one group of inhibitors that target mitotic kinesins. I will discuss the results of phase I and II trials with these drugs and place the results of these trials in a context to explain how they can be utilized in future human studies.",

author = "Rosenfeld, {Steven S.}",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media Dordrecht 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-94-017-9732-0_4",

language = "English (US)",

isbn = "9789401797313",

pages = "63--76",

booktitle = "Kinesins and Cancer",

publisher = "Sense Publishers",

}

TY - CHAP

T1 - Clinical trials of mitotic kinesin inhibitors

AU - Rosenfeld, Steven S.

N1 - Publisher Copyright: © Springer Science+Business Media Dordrecht 2015.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Abnormal mitotic activity underlies the pathology of a number of human diseases, most notably cancer, and has motivated the search for more specific and less toxic inhibitors of the mitotic process. In this chapter, I review the clinical experience with one group of inhibitors that target mitotic kinesins. I will discuss the results of phase I and II trials with these drugs and place the results of these trials in a context to explain how they can be utilized in future human studies.

AB - Abnormal mitotic activity underlies the pathology of a number of human diseases, most notably cancer, and has motivated the search for more specific and less toxic inhibitors of the mitotic process. In this chapter, I review the clinical experience with one group of inhibitors that target mitotic kinesins. I will discuss the results of phase I and II trials with these drugs and place the results of these trials in a context to explain how they can be utilized in future human studies.

UR - http://www.scopus.com/inward/record.url?scp=84943173110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943173110&partnerID=8YFLogxK

U2 - 10.1007/978-94-017-9732-0_4

DO - 10.1007/978-94-017-9732-0_4

M3 - Chapter

AN - SCOPUS:84943173110

SN - 9789401797313

SP - 63

EP - 76

BT - Kinesins and Cancer

PB - Sense Publishers

ER -

Clinical trials of mitotic kinesin inhibitors

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this